• DOI:10.1016/j.clinthera.2010.08.008
Corpus ID: 37383203

Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.

@article{Emerson2010DexlansoprazoleAP,
  title={Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system.},
  author={Christopher R. Emerson and Nino Marzella},
  journal={Clinical therapeutics},
  year={2010},
  volume={32 9},
  pages={
          1578-96
        }
}

• Christopher R. Emerson, Nino Marzella
• Published 2010
• Medicine
• Clinical therapeutics

BACKGROUND Dexlansoprazole, the dextrorotatory enantiomer of lansoprazole, is a proton pump inhibitor (PPI) formulated to have dual delayed-release properties. It is indicated for healing all grades of esophagitis, maintaining the healing of erosive esophagitis (EE), and treating heartburn associated with nonerosive gastroesophageal reflux disease. OBJECTIVE This article reviews the pharmacology, pharmacokinetics, and pharmacodynamics of dexlansoprazole, as well as its clinical efficacy and… Expand

View on PubMed

pillbuys.com

Save to Library

Create Alert

Cite

Launch Research Feed